A virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease
Transcatheter Interventions Online has fostered a truly global audience of thousands of HCPs engaged in coronary and structural heart treatment strategies.
Whilst the event’s international appeal and clinical impact continue to grow, recent years have seen the emergence of widespread demand among US-based HCPs for an event day dedicated exclusively to the challenges and treatment strategies most applicable in US practice.
As such, for the first time, 2025 will see the launch of Transcatheter Interventions Online I US Focus – a new fourth day of the TIO event, that will bring together opinion leaders and case centers of national excellence. The goal: to disseminate best practice, discuss common challenges and showcase technologies and treatment strategies that are driving superior outcomes in US practice.
Register now to join us on 12 April 2025 for the inaugural Transcatheter Interventions Online I US Focus.
Join the conversation - #TIOCongress2025
*Transcatheter Interventions Online 2025 US Focus programme will be submitted for CME accreditation.
(Please note this programme is subject to change)
Day 4 | US Focus - 12 April
US Focus - Coronary Sessions
Day Four Welcome

Session 4.1
Renal Denervation – Time for Action
Chair: Ajay Kirtane, New York, US
Panel: Jeremy Bock, Arlington, US; Naomi Fisher, Boston, US; Antonio Gutierrez, Durham, US; Matheen Khuddus, Gainesville, US; Eric Secemsky, Boston, US; Raven Voora, Chapel Hill, US
Which Patients Benefit From RDN – Naomi Fisher
How to Set Up a RDN Programme in 2025 – Jeremy Bock
Case Presentation – Eric Secemsky
Case Presentation – Antonio Gutierrez







Session 4.2
DCBs in Contemporary Practice
Chair: Ajay Kirtane, New York, US
Panel: Suhail Dohad, Los Angeles, US; Kathleen Kearney, Seattle, US; Azeem Latib, New York, US; Margaret McEntegart, New York, US
What Are DCBs and Why and How Do I Use Them? – Azeem Latib
Case Presentation – Kathleen Kearney




Session 4.3
Approaching Calcified Lesions in 2025
Chair: Ajay Kirtane, New York, US
Panel: Suhail Dohad, Los Angeles, US; Kathleen Kearney, Seattle, US; Margaret McEntegart , New York, US
What’s Our Strategy? – Margaret McEntegart
What Role Does Imaging Play? – Suhail Dohad




Session 4.4
Should Acute PE Intervention Be Performed Routinely by ICs?
Chair: Jay Giri, Philadelphia, US
Panel: Jay Mathews, Bradenton, US; Sahil Parikh, New York, US; Sonal Pruthi, New York, US; Sanjum Sethi, New York, US
Should Acute PE intervention be performed routinely by ICs? – Sahil Parikh
How to Set Up an Acute PE Program – Jay Mathews





US Focus - Structural Sessions
Session 4.5
Aortic Session
Chair: Azeem Latib, New York, US
Panel: Sebastian Iturra, Minneapolis, US; Amar Krishnaswamy, Cleveland, US, Susheel Kodali, New York, US; Andrea Scotti, New York, US; Nicolas Van Mieghem, Rotterdam, NL
TAVR in Younger Patients – Where Do We Stand? – Andrea Scotti
Case-In-A-Box With Discussion – TAVR in TAVR / TAVR Explant – Sebastian Iturra
The Future – Amar Krishnaswamy






Session 4.6
Mitral Session
Chair: Azeem Latib, New York, US
Panel: Anita Asgar Chicago, US; Manaf Assafin, New York, US; Neil Fam, Toronto, CA; Susheel Kodali, New York, US; Scott Lim, Charlottesville, US; Nicolas Van Mieghem, Rotterdam, NL
Contemporary Mitral Valve Intervention in 2025 – Anita Asgar
Case-In-A-Box With Discussion – Emerging Technology – Manaf Assafin
The Future – Scott Lim







Session 4.7
Tricuspid Session
Chair: Azeem Latib, New York, US
Panel: Anita Asgar Chicago, US; Neil Fam, Toronto, CA; Edwin Ho, New York, US; Susheel Kodali, New York, US; Nicolas Van Mieghem, Rotterdam, NL
Contemporary Tricuspid Valve Intervention in 2025 – Edwin Ho
Case-in-a-box With Discussion – Emerging Technology – Neil Fam
The Future – Susheel Kodali






Management of Degenerative MR With TEER: An Evidence-based Guide
Symposium
Chair: Tarun Chakravarty, Los Angeles, US
Panel: Firas Zahr, Portland, US; Tom Cahill, Oxford, UK
Welcome and Introduction
Transcatheter Repair: Selection in Degenerative MR
Making Evidence-based Decisions in TEER – Insights From Recent Clinical Data
Technical Considerations for TEER in DMR Patients
Panel Discussion and Q&A
This symposium is supported by an unrestricted educational grant from Edwards Lifesciences.
*Management of Degenerative MR With TEER: An Evidence-based Guide’s programme will be submitted for CME accreditation.




Ajay Kirtane
Course co-director
Columbia University Medical Center and New York-Presbyterian Hospital, New York, US
more info

Azeem Latib
Course co-director
Montefiore Medical Center, New York, US
more info
Faculty

Anita Asgar
Northwestern University, Chicago, US

Manaf Assafin
New York, US

Jeremy Bock
Arlington, US

Tom Cahill
Oxford, UK

Tarun Chakravarty
Los Angeles, US

Suhail Dohad
Los Angeles, US

Neil Fam
Toronto, CA

Naomi Fisher
Boston, US

Jay Giri
Philadelphia, US

Antonio Gutierrez
Durham, US

Edwin Ho
New York, US

Sebastian Iturra
Minneapolis, US

Kathleen Kearney
Seattle, US

Matheen Khuddus
Gainesville, US

Susheel Kodali
New York, US

Amar Krishnaswamy
Cleveland, US

Scott Lim
Charlottesville, US

Jay Matthews
Bradenton, US

Margaret McEntegart
Columbia University Medical Center and New York-Presbyterian Hospital, New York, US

Sahil Parikh
New York, US

Sonal Pruthi
New York, US

Andrea Scotti
New York, US

Eric Secemsky
Boston, US

Sanjum Sethi
New York, US

Nicolas Van Mieghem
Thoraxcenter, Erasmus MC, Rotterdam, NL

Raven Voora
Chapel Hill, US

Firas Zahr
Portland, US
Following the activities, participants will be able to:
- Examine Drug-Coated Balloons (DCBs) in coronary procedures
- Review advancements in Renal Denervation for hypertension
- Understand strategies for managing calcified lesions and imaging
- Assess the need for routine acute PE intervention
- Explore contemporary mitral and tricuspid valve interventions and latest technologies
(Please note these learning objectives are subject to change)
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
Headline Educational Partner

Educational Partners



Supporting Partner



If you’re interested in becoming an educational partner at TIO, please contact sales@radcliffe-group.com
Official Journal
Interventional Cardiology: Reviews, Research, Resources (ICR³) is an international, English language, peer-reviewed journal that publishes articles continuously on ICRjournal.com. It aims to assist time-pressured physicians to stay abreast of key advances and opinions in interventional cardiology.
Led by Editor-in-Chief Peter O'Kane, along with Deputy Editors and an editorial board of world-renowned physicians, the journal publishes peer-reviewed articles that aim to provide timely updates on the most pertinent issues in the field.
View the 2024 volume of ICR3
About Radcliffe Cardiology
We are Radcliffe, a knowledge network for the cardiovascular community
We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.
We bring medical knowledge to life
From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.
Our work is underpinned by 3 core principles:
- We build on the best science
- We work hands-on with our community
- We bring fresh thinking
Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.
For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com